Phosphorus genomics startup raises $10 million to test fertility
As the world of DNA sequencing becomes more efficient and less expensive, a number of companies are sprouting up within the space. The latest, Phosphorus, has just raised a $10 million Series A led by FirstMark.
Phosphorus is actually a spin-out from a previous genomics company called Recombine, which sold to CooperSurgical last year in a transaction valued at $85 million.
Recombine, led by Alexander Bisignano, offered a medical test that would sequence the genes of two parents who were trying to get pregnant, letting them know of any potential genetic disorders or recessive mutations that might affect their child.Read the full article on TechCrunch